I. Holt et Mj. Marshall, INTEGRIN SUBUNIT BETA-3 PLAYS A CRUCIAL ROLE IN THE MOVEMENT OF OSTEOCLASTS FROM THE PERIOSTEUM TO THE BONE SURFACE, Journal of cellular physiology, 175(1), 1998, pp. 1-9
We have shown that, when mouse parietal bones were incubated in cultur
e medium containing indomethacin, the number of tartrate-resistant aci
d phosphatase-positive osteoclasts (TRAP + OCs) on the bone surface wa
s drastically reduced (down-regulation), and the number on the periost
eal membrane adjacent to the resorbing surface was increased. Subseque
nt incubation of bones with prostaglandin E2 (PGE2) rapidly reversed t
hese changes (up-regulation). In the work reported here, the osteoclas
t-associated integrin subunit beta 3 was stained by immunohistochemist
ry. The beta 3-positive osteoclast (beta 3 + OC) population on freshly
isolated bone was comprised of about 67% TRAP + OCs and 33% TRAP - OC
s. Like TRAP + OCs, beta 3 + OCs were reduced in number on the surface
of bones incubated with indomethacin, but, in contrast to the TRAP OCs, beta 3 + OCs were not seen on the periosteal membrane. Following
up-regulation of TRAP + OCs with PGE2, large numbers of beta 3 + OCs a
ppeared on the bone surface and, again, were not seen on the periostea
l membrane. Echistatin, a peptide that binds to the alpha nu beta 3 in
tegrin on osteoclasts, was found to inhibit the up-regulation of TRAP
+ OCs in a dose-dependent manner but had no effect on the down-regulat
ion of TRAP + OCs. Similarly, echistatin inhibited the upregulation of
beta 3 + OCs on the bone surface, and, under these conditions, beta 3
+ OCs were observed on the periosteal membrane. The addition of anti-
beta 3 antibody also inhibited the up-regulation of TRAP + OCs in resp
onse to PGE2. The association of beta 3 protein expression with the up
-regulated osteoclast and the inhibition of up-regulation by echistati
n and by anti-beta 3 antibody provide strong evidence that beta 3 play
s an essential role in the movement of osteoclasts from the membrane t
o the bone. (C) 1998 Wiley-Liss, Inc.